Cyclen-based cationic lipids for highly efficient gene delivery towards tumor cells

Area of Science:

• Biotechnology
• Materials Science
• Molecular Biology

Background:

• Gene therapy holds significant promise for treating inherited and acquired diseases.
• Effective gene delivery remains a critical challenge, necessitating novel vehicles with low cytotoxicity and high transfection efficiency.

Purpose of the Study:

• To design and synthesize novel amphiphilic cationic lipids for gene delivery.
• To evaluate the DNA binding, nanoparticle formation, in vitro gene transfection efficiency, and cytotoxicity of these novel lipids.

Main Methods:

• Synthesis of three amphiphilic molecules (L1-L3) incorporating cyclen, imidazolium, and dodecyl chains.
• Characterization of DNA-lipid interactions using electrophoretic gel retardation, fluorescent quenching, dynamic light scattering, and transmission electron microscopy.
• Assessment of in vitro gene transfection and cytotoxicity in multiple cell lines.

Main Results:

• Liposomes formed by L1 and L3 effectively bound DNA, forming well-shaped nanoparticles.
• L3, combined with DOPE, exhibited high gene transfer efficiency in tumor cell lines (A549, HepG2, H460), outperforming Lipofectamine 2000™ by 5.5 times in A549 cells.
• L1 and L3 showed minimal gene transfection in normal HEK293 cells, indicating tumor-targeting potential, with low overall cytotoxicity.

Conclusions:

• Novel cyclen-based cationic lipids were developed for effective in vitro gene transfection.
• These findings suggest potential for expanding the applications of macrocyclic polyamines, particularly cyclen, in gene therapy.